{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-004638","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2023-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.269673+00:00","generated_at":"2026-06-09T21:53:33.703906+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"BiomX appoints Eddie Williams as Class I Director to fill board vacancy","bullets":["Eddie Williams appointed Class I Director, term expires at 2024 annual meeting.","Williams is independent under NYSE American rules and entered indemnification agreement.","He currently serves on BioAtla (BCAB) board; previously Catalyst Biosciences (CBIO) board.","Previously SVP at Novo Nordisk and VP at Novartis; over 20 years pharma experience.","Appointment effective October 12, 2023; no arrangement with any other person."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-004638","json":"https://secwatch.observer/filing/0001013762-23-004638.json","markdown":"https://secwatch.observer/filing/0001013762-23-004638.md","text":"https://secwatch.observer/filing/0001013762-23-004638.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000101376223004638/0001013762-23-004638-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000101376223004638/ea186892-8k_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T21:53:33.703906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"59121434d8","claim":"Eddie Williams was appointed as Class I Director at BiomX Inc..","evidence_excerpt":"On October 12, 2023, the Board of Directors (the “Board”) of BiomX Inc. (the “Company”), pursuant to a recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Eddie Williams to serve as Class I Director of the Company, with a term expiring at the Company’s 2024 annual meeting of stockholders, in order to fill an existing vacancy on the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000101376223004638/0001013762-23-004638-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}